Evaluating mitochondrial DNA in patients with breast cancer and benign breast disease

By Shen Lijun   Wei Jia   Chen Tao   He Jing   Qu Jianchun   He Xiumei   Jiang Luxi   Qu Yemin   Fang Hezhi   Chen Guorong   Lu Jianxin   Bai Yidong  

Journal of Cancer Research and Clinical Oncology, Vol. 137, Iss. 4, 2011-04 ,pp. : 669-675

Springer Publishing Company

Access to resources Recommend Favorite

VEGF 936C>T polymorphism and breast cancer risk: evidence from 5,729 cases and 5,868 controls

By Gu Dongying  

Breast Cancer Research and Treatment, Vol. 125, Iss. 2, 2011-01 ,pp. : 489-493

Springer Publishing Company

Access to resources Recommend Favorite

Association between CYP19 polymorphisms and breast cancer risk: results from 10,592 cases and 11,720 controls

By Ma Xiangyu   Qi Xiaowei   Chen Chunhai   Lin Hui   Xiong Hongyan   Li Yafei   Jiang Jun  

Breast Cancer Research and Treatment, Vol. 122, Iss. 2, 2010-07 ,pp. : 495-501

Springer Publishing Company

Access to resources Recommend Favorite

Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls

By Qi Xiaowei  

Breast Cancer Research and Treatment, Vol. 123, Iss. 2, 2010-09 ,pp. : 499-506

Springer Publishing Company

Access to resources Recommend Favorite

Elevated Luteinizing Hormone in Serum, Breast Cancer Tissue, and Normal Breast Tissue from Breast Cancer Patients

By Silva E.G.  

Breast Cancer Research and Treatment, Vol. 76, Iss. 2, 2002-11 ,pp. : 125-130

Springer Publishing Company

Access to resources Recommend Favorite